OR WAIT null SECS
August 13, 2021
The companies announce the results of a research collaboration that applied machine learning to significantly advance the scalability of spirulina-based biologic drugs.
Bayer has acquired Vividion Therapeutics, a US-based biopharmaceutical company.
Recro acquires CDMO IRISYS, establishing a bi-coastal presence in the US.
August 12, 2021
FDA has awarded Fast Track designation to Vivet Therapeutics’ novel gene therapy, VTX-801.
Veraxa and Indivumed will work together to develop colorectal antibody drugs.
Moderna will build an mRNA vaccine manufacturing facility in Canada to provide access to domestically manufactured vaccines against respiratory viruses.
The EC has approved the drug in the EU for treatment of chronic kidney disease in adults with or without type-2 diabetes.
August 11, 2021
The MHRA has approved GW Pharmaceuticals’ Epidiolex for the treatment of seizures associated with tuberous sclerosis complex.
August 09, 2021
KVK Tech is voluntarily recalling two lots of Atovaquone Oral Suspension, USP 750 mg/5mL because of customer complaints of unusual grittiness in the product.
FDA has approved the intravenous medication Nexviazyme for treatment of Pompe Disease.